Cargando…

Shuttling Tolerogenic Dendritic Cells across the Blood–Brain Barrier In Vitro via the Introduction of De Novo C–C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation

The use of tolerance-inducing dendritic cells (tolDCs) has been proven to be safe and well tolerated in the treatment of autoimmune diseases. Nevertheless, several challenges remain, including finding ways to facilitate the migration of cell therapeutic products to lymph nodes, and the site of infla...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Laere, Maxime, Derdelinckx, Judith, Hassi, Mari, Kerosalo, Mari, Oravamäki, Heidi, Van den Bergh, Johan, Berneman, Zwi, Cools, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778265/ https://www.ncbi.nlm.nih.gov/pubmed/29403473 http://dx.doi.org/10.3389/fimmu.2017.01964

Ejemplares similares

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy
por: Campillo-Davo, Diana, et al.
Publicado: (2021)

Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner
por: Van Delen, Mats, et al.
Publicado: (2022)

To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis
por: De Laere, Maxime, et al.
Publicado: (2018)

Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future
por: Derdelinckx, Judith, et al.
Publicado: (2021)

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA
por: Derdelinckx, Judith, et al.
Publicado: (2019)

A Microfluidic In Vitro Three-Dimensional Dynamic Model of the Blood–Brain Barrier to Study the Transmigration of Immune Cells
por: Meena, Megha, et al.
Publicado: (2022)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood–Brain Barrier under Inflammatory Conditions In Vitro
por: De Laere, Maxime, et al.
Publicado: (2017)

Transmigration across a Steady-State Blood–Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization
por: Meena, Megha, et al.
Publicado: (2021)

Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System
por: Van Brussel, Ilse, et al.
Publicado: (2012)

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration
por: Willekens, Barbara, et al.
Publicado: (2019)

HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients
por: Derdelinckx, Judith, et al.
Publicado: (2020)

Neuroendocrine Immunoregulation in Multiple Sclerosis
por: Deckx, Nathalie, et al.
Publicado: (2013)

Dendritic Cells: Cellular Mediators for Immunological Tolerance
por: Chung, Chun Yuen J., et al.
Publicado: (2013)

Regulatory T Cells and Human Disease
por: Cools, Nathalie, et al.
Publicado: (2007)

cGAMP the travelling messenger
por: Blest, Henry T. W., et al.
Publicado: (2023)

Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells
por: Van Craenenbroeck, Amaryllis H., et al.
Publicado: (2015)

Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction
por: de Haas, A. H., et al.
Publicado: (2007)

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
por: Anguille, Sébastien, et al.
Publicado: (2009)

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer
por: de Bruijn, Sévérine, et al.
Publicado: (2019)

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA
por: Campillo-Davo, Diana, et al.
Publicado: (2020)

Immunomodulatory Effects of 1,25-Dihydroxyvitamin D(3) on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
por: Lee, Wai-Ping, et al.
Publicado: (2016)

Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC
por: Lion, Eva, et al.
Publicado: (2011)

“Direct cloning in Lactobacillus plantarum: Electroporation with non-methylated plasmid DNA enhances transformation efficiency and makes shuttle vectors obsolete”
por: Spath, Katharina, et al.
Publicado: (2012)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

SR proteins: To shuttle or not to shuttle, that is the question
por: Hammarskjold, Marie-Louise, et al.
Publicado: (2017)

C-C Chemokine Receptor 7 in Cancer
por: Bill, Colin A., et al.
Publicado: (2022)

A synthetic C4 shuttle via the β-hydroxyaspartate cycle in C3 plants
por: Roell, Marc-Sven, et al.
Publicado: (2021)

Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8(+ )T cells with peptide-pulsed autologous dendritic cells
por: Cools, Nathalie, et al.
Publicado: (2006)

Identification of C-C Chemokine Receptor 1 (CCR1) as the Monocyte Hemofiltrate C-C Chemokine (HCC)-1 Receptor
por: Tsou, Chia-Lin, et al.
Publicado: (1998)

Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1
por: De Luca, Elisa, et al.
Publicado: (2021)

Riboswitches in eubacteria sense the second messenger c-di-AMP
por: Nelson, James W., et al.
Publicado: (2013)

Differentiation between first and second messenger effects of cGMP
por: Schneider, Erich, et al.
Publicado: (2015)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

Human Tears Reveal Insights into Corneal Neovascularization
por: Zakaria, Nadia, et al.
Publicado: (2012)

Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort
por: Ten Brinke, Anja, et al.
Publicado: (2015)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015)

Electroporation of cDNA/Morpholinos to targeted areas of embryonic CNS in Xenopus
por: Falk, Julien, et al.
Publicado: (2007)

C(C)Learing the Role of Chemokines in Pulmonary Fibrosis
por: He, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2u09qmh8ktnir14ui0tu35beol